Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Ítems similars

• Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
  per: Donghee Kim, et al.
  Publicat: (2025-04-01)
• Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
  per: Pojsakorn Danpanichkul, et al.
  Publicat: (2025-01-01)
• Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
  per: Donghee Kim, et al.
  Publicat: (2025-04-01)
• From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
  per: Ming-Lun Yeh, et al.
  Publicat: (2023-10-01)
• Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
  per: Donghee Kim, et al.
  Publicat: (2024-10-01)